10-Q Filing

UNI-PIXEL CIK: 1171012 Q3 2014

Filing Information

Form Type	10-Q
Accession Number	`0001185185-14-002942`
Period End Date	20140930
Filing Date	20141106
Fiscal Year	2014
Fiscal Period	Q3
XBRL Instance	unxl-20140930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 47 Income Statement 49 Cash Flow Statement 55 Stockholders Equity 29

Balance Sheet 47 line items

Line Item	Tag	Value	Unit	Period
Accumulated depreciation (in Dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$4.77M	USD	Point-in-time
Accumulated depreciation (in Dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$9.30M	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$26.82M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$46.63M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$13.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$39.37M	USD	Point-in-time
Account receivable, net	`AccountsReceivableNetCurrent`	$11.41K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	12.35M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	12.24M	shares	Point-in-time
Account receivable, net	`AccountsReceivableNetCurrent`	-	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$95.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	12.35M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	-	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	12.24M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$39.38M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$26.92M	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $9,303,673 and $4,769,453, at September 30, 2014 and December 31, 2013, respectively	`PropertyPlantAndEquipmentNet`	$15.89M	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $9,303,673 and $4,769,453, at September 30, 2014 and December 31, 2013, respectively	`PropertyPlantAndEquipmentNet`	$12.51M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$17.44K	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$17.44K	USD	Point-in-time
Total assets	`Assets`	$39.44M	USD	Point-in-time
Total assets	`Assets`	$55.29M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$256.41K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.05M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$5.00M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$5.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$6.05M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.26M	USD	Point-in-time
Total liabilities	`Liabilities`	$5.26M	USD	Point-in-time
Total liabilities	`Liabilities`	$6.05M	USD	Point-in-time
Commitments and contingencies (Note 3)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 3)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 100,000,000 shares authorized, 12,350,715 shares issued and outstanding at September 30, 2014 and 12,244,714 shares issued and outstanding at December 31, 2013	`CommonStockValue`	$12.24K	USD	Point-in-time
Common stock, $0.001 par value; 100,000,000 shares authorized, 12,350,715 shares issued and outstanding at September 30, 2014 and 12,244,714 shares issued and outstanding at December 31, 2013	`CommonStockValue`	$12.35K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$135.72M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$138.54M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-104.37M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-86.49M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$34.19M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$49.24M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$14.37M	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$55.29M	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$39.44M	USD	Point-in-time

Income Statement 49 line items

Line Item	Tag	Value	Unit	Period
Revenue	`SalesRevenueNet`	-	USD	1 Quarter
Revenue	`SalesRevenueNet`	-	USD	1 Quarter
Revenue	`SalesRevenueNet`	$5.07M	USD	3 Qtrs
Revenue	`SalesRevenueNet`	-	USD	3 Qtrs
Cost of revenues	`CostOfRevenue`	$3.42K	USD	3 Qtrs
Cost of revenues	`CostOfRevenue`	-	USD	3 Qtrs
Cost of revenues	`CostOfRevenue`	-	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	-	USD	1 Quarter
Gross margin	`GrossProfit`	$5.07M	USD	3 Qtrs
Gross margin	`GrossProfit`	-	USD	3 Qtrs
Gross margin	`GrossProfit`	-	USD	1 Quarter
Gross margin	`GrossProfit`	-	USD	1 Quarter
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$6.83M	USD	3 Qtrs
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$2.48M	USD	1 Quarter
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$8.88M	USD	3 Qtrs
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$2.93M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.69M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$7.29M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.83M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$9.01M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-9.06M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-5.31M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-17.89M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-5.62M	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$13.30K	USD	3 Qtrs
Interest income, net	`InterestIncomeExpenseNet`	$3.90K	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$6.83K	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$12.76K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-5.30M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.62M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-15.18M	USD	Annual
Net loss	`NetIncomeLoss`	$-17.87M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-9.05M	USD	3 Qtrs
Net loss - basic (in Dollars per share)	`EarningsPerShareBasic`	$-1.45	USD	3 Qtrs
Net loss - basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.45	USD	1 Quarter
Net loss - basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.80	USD	3 Qtrs
Net loss - basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.44	USD	1 Quarter
Net loss - diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.45	USD	1 Quarter
Net loss - diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.44	USD	1 Quarter
Net loss - diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-1.45	USD	3 Qtrs
Net loss - diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.80	USD	3 Qtrs
Weighted average number of basic common shares outstanding (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	12.35M	shares	1 Quarter
Weighted average number of basic common shares outstanding (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	12.32M	shares	3 Qtrs
Weighted average number of basic common shares outstanding (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	11.27M	shares	3 Qtrs
Weighted average number of basic common shares outstanding (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	12.09M	shares	1 Quarter
Weighted average number of diluted common shares outstanding (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.09M	shares	1 Quarter
Weighted average number of diluted common shares outstanding (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.35M	shares	1 Quarter
Weighted average number of diluted common shares outstanding (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	11.27M	shares	3 Qtrs
Weighted average number of diluted common shares outstanding (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.32M	shares	3 Qtrs

Cash Flow Statement 55 line items

Line Item	Tag	Value	Unit	Period
Issuance of Common for Cashless Exercise of Warrants	`StockIssuedDuringPeriodSharesOther`	399,629.00	shares	3 Qtrs
Issuance of Common for Cashless Exercise of Warrants	`StockIssuedDuringPeriodSharesOther`	64,699.00	shares	3 Qtrs
Net loss	`NetIncomeLoss`	$-5.30M	USD	1 Quarter
Cashless Exercise of Warrants	`ClassOfWarrantOrRightsExercised`	505,661.00	shares	3 Qtrs
Cashless Exercise of Warrants	`ClassOfWarrantOrRightsExercised`	126,433.00	shares	3 Qtrs
Net loss	`NetIncomeLoss`	$-5.62M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-15.18M	USD	Annual
Net loss	`NetIncomeLoss`	$-17.87M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-9.05M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$1.23M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$4.53M	USD	3 Qtrs
Restricted stock issuance	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$936.51K	USD	3 Qtrs
Restricted stock issuance	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$1.31M	USD	3 Qtrs
Stock compensation expense	`ShareBasedCompensation`	$2.41M	USD	3 Qtrs
Stock compensation expense	`ShareBasedCompensation`	$1.84M	USD	3 Qtrs
Decrease in accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-11.41K	USD	3 Qtrs
Decrease in accounts receivable	`IncreaseDecreaseInAccountsReceivable`	-	USD	3 Qtrs
(Increase) decrease in prepaid assets and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-160.32K	USD	3 Qtrs
(Increase) decrease in prepaid assets and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$95.00K	USD	3 Qtrs
Increase (decrease) in accounts payable	`IncreaseDecreaseInAccountsPayable`	$879.39K	USD	3 Qtrs
Increase (decrease) in accounts payable	`IncreaseDecreaseInAccountsPayable`	$-797.34K	USD	3 Qtrs
Increase in bonus accrual	`IncreaseDecreaseInOtherAccruedLiabilities`	-	USD	3 Qtrs
Increase in bonus accrual	`IncreaseDecreaseInOtherAccruedLiabilities`	$273.68K	USD	3 Qtrs
Increase in deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$5.00M	USD	3 Qtrs
Increase in deferred revenue	`IncreaseDecreaseInDeferredRevenue`	-	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-11.44M	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$2.22M	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.15M	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$13.26M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.15M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-13.26M	USD	3 Qtrs
Proceeds from exercise of warrants, net	`ProceedsFromWarrantExercises`	$175.98K	USD	3 Qtrs
Proceeds from exercise of warrants, net	`ProceedsFromWarrantExercises`	-	USD	3 Qtrs
Proceeds from exercise of stock options, net	`ProceedsFromStockOptionsExercised`	$41.64K	USD	3 Qtrs
Proceeds from exercise of stock options, net	`ProceedsFromStockOptionsExercised`	$3.28M	USD	3 Qtrs
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$41.22M	USD	3 Qtrs
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	-	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$44.68M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$41.64K	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-12.55M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$33.63M	USD	3 Qtrs
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$39.37M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$13.00M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$26.82M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$46.63M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$26.82M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$46.63M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$13.00M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$39.37M	USD	Point-in-time
Cash paid for interest	`InterestPaid`	-	USD	3 Qtrs
Cash paid for interest	`InterestPaid`	-	USD	3 Qtrs
Cash paid for income taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs
Cash paid for income taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs
Issuance of 64,699 shares of common stock in exchange for the cashless exercise of warrants to purchase 126,433 shares of common stock for the nine months ended September 30, 2014. Issuance of 399,629 shares of common stock in exchange for the cashless exercise of warrants to purchase 505,661 shares of common stock for the nine months ended September 30, 2013.	`StockIssued1`	$2.15M	USD	3 Qtrs
Issuance of 64,699 shares of common stock in exchange for the cashless exercise of warrants to purchase 126,433 shares of common stock for the nine months ended September 30, 2014. Issuance of 399,629 shares of common stock in exchange for the cashless exercise of warrants to purchase 505,661 shares of common stock for the nine months ended September 30, 2013.	`StockIssued1`	$323.49K	USD	3 Qtrs

Stockholders Equity 29 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$34.19M	USD	Point-in-time
Balance	`StockholdersEquity`	$49.24M	USD	Point-in-time
Balance	`StockholdersEquity`	$14.37M	USD	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	12.35M	shares	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	12.24M	shares	Point-in-time
Stock compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$3.41M	USD	Annual
Stock compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.84M	USD	3 Qtrs
Exercise of warrants	`StockIssuedDuringPeriodValueOther`	$187.98K	USD	Annual
Exercise of warrants (in Shares)	`StockIssuedDuringPeriodSharesOther`	399,629.00	shares	3 Qtrs
Exercise of warrants (in Shares)	`StockIssuedDuringPeriodSharesOther`	64,699.00	shares	3 Qtrs
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$41.64K	USD	3 Qtrs
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$3.51M	USD	Annual
Exercise of stock options (in Shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	5,668.00	shares	3 Qtrs
Exercise of stock options (in Shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	491,801.00	shares	3 Qtrs
Issuance of restricted stock	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$1.72M	USD	Annual
Issuance of restricted stock	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$936.51K	USD	3 Qtrs
Issuance of restricted stock (in Shares)	`StockIssuedDuringPeriodSharesRestrictedStockAwardGross`	35,634.00	shares	3 Qtrs
Issuance of common stock, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$41.22M	USD	Annual
Issuance of common stock, net of issuance costs (in Shares)	`StockIssuedDuringPeriodSharesNewIssues`	1.37M	shares	3 Qtrs
Net loss	`NetIncomeLoss`	$-5.30M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.62M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-15.18M	USD	Annual
Net loss	`NetIncomeLoss`	$-17.87M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-9.05M	USD	3 Qtrs
Balance	`StockholdersEquity`	$34.19M	USD	Point-in-time
Balance	`StockholdersEquity`	$49.24M	USD	Point-in-time
Balance	`StockholdersEquity`	$14.37M	USD	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	12.35M	shares	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	12.24M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.